Nuvation Bio Balance Sheet
NYSE: NUVBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Nuvation Bio financial position
At the end of fiscal 2025, Nuvation Bio reported total assets of $594.8 million, up 10.0% from a year earlier against total liabilities of $289.1 million. Shareholders' equity stood at $305.7 million, or 51.4% of assets. The company held $164.1 million in cash and equivalents against $52.9 million of debt, a net cash position of $111.2 million.
The current ratio (current assets divided by current liabilities) was 6.95, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.17.
Summary generated from market data by MetaCap's automated system. Methodology
Nuvation Bio balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 164.09M | 35.72M | 42.65M | 101.10M | 132.42M | 29.75M |
| Short-Term Investments | 365.13M | 466.97M | 568.56M | 559.91M | 632.97M | 186.00M |
| Inventory | 11.41M | 0 | — | — | — | — |
| Total Current Assets | 571.52M | 526.25M | 616.43M | 667.32M | 772.07M | 220.68M |
| Property, Plant & Equipment | 564.00K | 586.00K | 717.00K | 894.00K | 786.00K | 688.00K |
| Intangible Assets | 11.21M | 4.62M | 0 | — | — | — |
| Total Assets | 594.82M | 540.63M | 621.48M | 672.14M | 776.15M | 221.79M |
| Accounts Payable | 9.48M | 6.35M | 2.21M | 2.14M | 3.92M | 2.17M |
| Short-Term Debt | 5.72M | 6.28M | 0 | — | — | — |
| Total Current Liabilities | 82.23M | 58.24M | 13.97M | 13.16M | 16.93M | 6.55M |
| Long-Term Debt | 47.21M | 0 | — | — | — | — |
| Total Liabilities | 289.11M | 76.84M | 16.36M | 17.07M | 30.15M | 6.71M |
| Shareholders' Equity | 305.72M | 463.79M | 605.12M | 655.08M | 746.00M | 215.08M |
| Retained Earnings | -1.12B | -910.74M | -342.80M | -267.00M | -162.80M | -75.95M |
| Total Debt | 52.93M | 6.28M | 0 | — | — | — |
| Net Cash (Debt) | 476.28M | 496.41M | 611.21M | 661.01M | 765.39M | 215.75M |
| Shares Outstanding | 346.50M | 337.84M | 219.05M | 218.63M | 217.95M | 149.04M |
This table shows 6 annual periods of Nuvation Bio's balance sheet, from FY 2025 back to FY 2020, across 17 line items including cash & equivalents, short-term investments, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow NUVB's reporting calendar. What is a balance sheet?